Alien Registration- St Pierre, Armand O. (Auburn, Androscoggin County)

https://digitalmaine.com/alien_docs/30336/thumbnail.jp

A Perfect Kiss : Un Baiser Parfait

https://digitalcommons.library.umaine.edu/mmb-vp/5326/thumbnail.jp

Distributions of highly branched isoprenoid alkenes and other algal lipids in surface waters from East Antarctica: Further insights for biomarker-based paleo sea-ice reconstruction

The occurrence and variable abundance of certain di- and tri-unsaturated C₂₅ highly branched isoprenoid (HBI) biomarkers in Antarctic marine sediments has previously been proposed as a possible proxy measure of paleo sea-ice extent in the Southern Ocean. In the current study, we obtained 47 near-surface (ca. 0-10 m) water samples taken from locations in East Antarctica with different sea ice settings and analysed them for their HBI, sterol and fatty acid content. Sampling locations ranged from the permanently open-ocean zone (POOZ), with no seasonal sea-ice cover, the near-shore summer sea ice zone (SIZ), where sea ice remains long into the summer melt season, and the marginal ice zone (MIZ), located between the POOZ and the SIZ, and with a highly variable latitudinal sea-ice edge throughout the season. A di-unsaturated C₂₅ HBI (diene II) was only identified in surface waters from the MIZ and the SIZ, consistent with a sea-ice diatom origin for this biomarker. In contrast, a tri-unsaturated C₂₅ HBI (triene III) was detected in all samples from the POOZ, the MIZ and the SIZ, and with a stable isotopic composition (δ¹³C = -35 ± 1.5‰) consistent with a phytoplankton source. The highest concentrations of diene II and triene III were in samples from the SIZ and the MIZ, respectively, thus providing further insights into the sea-ice conditions likely favourable for their production and how their relative abundances (the II/III ratio) in underlying sediments might be better interpreted for paleo sea-ice reconstruction. In this respect, relatively high II/III might be a good indicator of extended (into summer) seasonal sea-ice cover, while lower II/III may provide a better indicator of the MIZ. However, the observation of highly variable II/III within the polynya setting of the SIZ may also have significant impacts on sedimentary values. Distributions of diatom sterols and fatty acids were also variable between the three sampling zones, but these were not as distinctive as those observed for the HBIs.10 page(s

Source identification and distribution reveals the potential of the geochemical Antarctic sea ice proxy IPSO25

The presence of a di-unsaturated highly branched isoprenoid (HBI) lipid biomarker (diene II) in Southern Ocean sediments has previously been proposed as a proxy measure of palaeo Antarctic sea ice. Here we show that a source of diene II is the sympagic diatom Berkeleya adeliensis Medlin. Furthermore, the propensity for B. adeliensis to flourish in platelet ice is reflected by an offshore downward gradient in diene II concentration in >100 surface sediments from Antarctic coastal and near-coastal environments. Since platelet ice formation is strongly associated with super-cooled freshwater inflow, we further hypothesize that sedimentary diene II provides a potentially sensitive proxy indicator of landfast sea ice influenced by meltwater discharge from nearby glaciers and ice shelves, and re-examination of some previous diene II downcore records supports this hypothesis. The term IPSO25-Ice Proxy for the Southern Ocean with 25 carbon atoms-is proposed as a proxy name for diene II

Iron chelation therapy in the myelodysplastic syndromes and aplastic anemia: a review of experience in South Korea

Emerging clinical data indicate that transfusion-dependent patients with bone marrow-failure syndromes (BMFS) are at risk of the consequences of iron overload, including progressive damage to hepatic, endocrine, and cardiac organs. Despite the availability of deferoxamine (DFO) in Korea since 1998, data from patients with myelodysplastic syndromes, aplastic anemia, and other BMFS show significant iron overload and damage to the heart and liver. The recent introduction of deferasirox, a once-daily, oral iron chelator, may improve the availability of iron chelation therapy to iron-overloaded patients, and improve compliance in patients who may otherwise find adherence to the DFO regimen difficult

Large expert-curated database for benchmarking document similarity detection in biomedical literature search

Document recommendation systems for locating relevant literature have mostly relied on methods developed a decade ago. This is largely due to the lack of a large offline gold-standard benchmark of relevant documents that cover a variety of research fields such that newly developed literature search techniques can be compared, improved and translated into practice. To overcome this bottleneck, we have established the RElevant LIterature SearcH consortium consisting of more than 1500 scientists from 84 countries, who have collectively annotated the relevance of over 180 000 PubMed-listed articles with regard to their respective seed (input) article/s. The majority of annotations were contributed by highly experienced, original authors of the seed articles. The collected data cover 76% of all unique PubMed Medical Subject Headings descriptors. No systematic biases were observed across different experience levels, research fields or time spent on annotations. More importantly, annotations of the same document pairs contributed by different scientists were highly concordant. We further show that the three representative baseline methods used to generate recommended articles for evaluation (Okapi Best Matching 25, Term Frequency-Inverse Document Frequency and PubMed Related Articles) had similar overall performances. Additionally, we found that these methods each tend to produce distinct collections of recommended articles, suggesting that a hybrid method may be required to completely capture all relevant articles. The established database server located at https://relishdb.ict.griffith.edu.au is freely available for the downloading of annotation data and the blind testing of new methods. We expect that this benchmark will be useful for stimulating the development of new powerful techniques for title and title/abstract-based search engines for relevant articles in biomedical research.Peer reviewe

B cell regulation of the anti-tumor response and role in carcinogenesis

The balance between immune effector cells such as T cells and natural killer cells, and immunosuppressive Treg cells, dendritic, myeloid and monocytic sub-populations in the tumor microenvironment acts to calibrate the immune response to malignant cells. Accumulating evidence is pointing to a role for B cells in modulating the immune response to both solid tumors and hematologic cancer. Evidence from murine autoimmune models has defined B regulatory cell (Breg) subsets that express cytokines such as IL-10, TGF-β, and/or express immune regulatory ligands such as PD-L1, which can suppress T cell and/or natural killer cell responses. Multiple murine tumor models exhibit decreased tumor growth in B cell deficient or B cell depleted mice. In several of these models, B cells inhibit T cell mediated tumor immunity and/or facilitate conversion of T cells to CD4(+)CD25(+)FoxP3(+) T regs, which act to attenuate the innate and/or adaptive antitumor immune response. Mechanisms of suppression include the acquisition of inhibitory ligand expression, and phosphorylation of Stat3, and induction of IL-10 and TGF-β, resulting in a Breg phenotype. Breg suppressive activity may affect diverse cell subtypes, including T effector cells, NK cells, myeloid derived suppressor cells (MDSC) and/or tumor associated macrophages. B cells may also directly promote tumorigenesis through recruitment of inflammatory cells, and upregulation of pro-angiogenic genes and pro-metastatic collagenases. Breg infiltration has now been identified in a variety of solid tumor malignancies including but not limited to ovarian, gastric, non-small cell lung cancer, pancreatic, esophageal, head and neck, and hepatocellular carcinomas. Increasing evidence suggests that recruitment of B cells and acquisition of suppressive activity within the tumor bed may be an important mechanism through which B cells may modulate innate and/or adaptive anti-tumor immunity. B cell depletion in the clinic using anti-CD20 antibodies and/or inhibitors of BTK and/or other signaling pathways, may be a useful strategy for augmenting the anti-tumor immune response

Alien Registration- St Pierre, Armand O. (Auburn, Androscoggin County)

https://digitalmaine.com/alien_docs/30336/thumbnail.jp